An excerpt of global consensus recommendations for metabolic dysfunction-associated steatotic liver disease and steatohepatitis(2025)
- VernacularTitle:《2025年代谢功能障碍相关脂肪性肝病和脂肪性肝炎全球共识建议》摘译
- Author:
Aifang LIU
1
;
Bo ZOU
;
Lei LUO
;
Jing ZHANG
;
Wenlong YANG
Author Information
- Publication Type:Journal Article
- Keywords: Metabolic Dysfunction-Associated Steatotic Liver Disease; Metabolic Dysfunction-Associated Steatohepatitis; Practice Guideline
- From: Journal of Clinical Hepatology 2025;41(8):1521-1524
- CountryChina
- Language:Chinese
- Abstract: In April 2025,Global consensus recommendations for metabolic dysfunction-associated steatotic liver disease and steatohepatitis was published online in Gastroenterology.These recommendations address the areas with significant divergence,such as metabolic dysfunction-associated steatotic liver disease(MASLD)screening steps,the use of noninvasive tests for risk stratification,management of comorbidities,and the recent advances in resmetirom for the treatment of metabolic dysfunction-associated steatohepatitis(MASH),covering the most debated topics in current MASLD management.This article makes an excerpt of the main contents in these consensus recommendations.
